Phase 1 Clinical Pharmacology Study

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Quotient has the experience and expertise to deliver studies with the highest quality service and speed to clinical data. If you need a complete service including data management, data analysis, statistics and medical writing, Quotient is your answer.

Radiolabeled ADME Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

In response to a growing interest in conducting human 14C-radiolabeled ADME studies earlier in drug development, Celerion has expanded its ADME suite in Lincoln, Nebraska.

14C ADME / Mass Balance

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

Whatever Phase 1 clinical pharmacology study you require, at Quotient Sciences you can expect rapid study startup and rapid recruitment through our locations in Jacksonville, Miami and Nottingham.

Clinical Development Services & Solutions

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Chiltern provides the following services for Phase llb - III Late-stage programs: Protocol feasibility and design, CRF development, Recruitment, Data management, Medical writing, Biostatistics, Drug safety monitoring committees

Early Development Clinical Research Services

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Program services offered by both clinics range from medical writing, clinical conduct and data management to monitoring, biostatistics and clinical pharmacology.

Supporting Drug Development at Phase III

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

Supporting Drug Development at Phase I & II

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

14C-Radiolabeled Microtracer Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

Celerion’s clinic in Lincoln, Nebraska, is the only Phase I facility in North America with proven experience to release radiolabeled drug to regulatory standards that has been formulated on site for intravenous use in humans. This is required to perform assessments of absolute bioavailability

Global CRO- Phase I & ll Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

With over 40 years of experience, more than 600 beds in North America and Europe, Celerion offers the largest global Phase I and II clinical operations networks in the industry.

Clinical PK/PD and Pharmacometrics Services

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

PAREXEL’s global team of experienced clinical pharmacokineticists and pharmacometricians offer unsurpassed expertise in Clinical PK/PD and Pharmacometrics, from pre-clinical to Phase III studies.